Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Swiss Medical Weekly|May 30, 2015
Idiopathic pulmonary fibrosis: the turning point is now!Manuela Funke, Thomas Geiser
Therapeutische Umschau. Revue Therapeutique|February 18, 2016
[Anti-fibrotics as novel therapy for idiopathic pulmonary fibrosis]Manuela Funke-Chambour, Thomas Geiser
Therapeutische Umschau. Revue Therapeutique|January 9, 2020
[Diagnostics of interstitial lung diseases in the multidisciplinary team]Sabina Berezowska, Alexander Pöllinger, Manuela Funke-Chambour
Swiss Medical Weekly|September 30, 2016
Pulmonary hypertension associated with chronic lung diseasesManuela Funke, Thomas Geiser, Otto D Schoch
Der Pathologe|January 30, 2020
[Idiopathic pulmonary fibrosis-epidemiology, causes, and clinical course]Stephan C Schäfer, Manuela Funke-Chambour, Sabina Berezowska
Der Pathologe|December 21, 2019
[The multidisciplinary discussion-the gold standard in diagnosing interstitial lung diseases]Sabina Berezowska, Manuela Funke-Chambour, Alexander Pöllinger, et al.
Respiratory Research|January 28, 2025
Fibrosis in PCLS: comparing TGF-β and fibrotic cocktailCarlos Machahua, Thomas M Marti, Patrick Dorn, et al.
Respiratory Research|November 15, 2017
Novel insights in cough and breathing patterns of patients with idiopathic pulmonary fibrosis performing repeated 24-hour-respiratory polygraphiesAnke Schertel, Manuela Funke-Chambour, Thomas Geiser, et al.
Respiratory Research|January 12, 2018
Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis - a potential biomarker role for LysoPCBarbara Rindlisbacher, Cornelia Schmid, Thomas Geiser, et al.
American Journal of Respiratory Cell and Molecular Biology|October 25, 2011
The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injuryManuela Funke, Zhenwen Zhao, Yan Xu, et al.
Pageof 7